Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone/Povidone-iodine for Viral Conjunctivitis
NCT01481519Phase 3Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Dec 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and povidone-iodine in viral conjunctivitis, sponsored by Universidade Estadual de Campinas. Primary endpoint: Conjunctival injection at 5 days. Started Dec 2011; status: completed.
02
Drugs
dexamethasonepovidone-iodine
03
Conditions
viral conjunctivitis
Beyond the preview
Go deeper on NCT01481519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481519.